bimekizumab
ucb pharmaceuticals
['bimekizumab', 'axspa']
coming soon: bimekizumab (inhibition of il-17a and f), efficacious for both nr-axspa and r-axspa plenty of data on this med during this meeting as well #acr22 #reviewcourse 
@bu_bmc_rheum | @rheum_covid @spartan_updates @official_asas | @UWRheum @UWEpidemiology 2020 | @OHSUIMres 2017 | @UTMBhealth 2014 | @UTAustin 2010